Lhermitte, L <br/><br/>
Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.  [electronic resource] 

 -  Leukemia  Oct 2006 
 - 1908-10 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2404349  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Division<br/>Diphtheria Toxin--pharmacology<br/>Humans<br/>Immunophenotyping<br/>Interleukin-3--pharmacology<br/>Interleukin-3 Receptor alpha Subunit<br/>Leukemia-Lymphoma, Adult T-Cell--drug therapy<br/>Receptors, Interleukin-3--metabolism<br/>Recombinant Fusion Proteins--pharmacology